These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 32202324)
1. Truncating mutations in SHANK3 associated with global developmental delay interfere with nuclear β-catenin signaling. Hassani Nia F; Woike D; Kloth K; Kortüm F; Kreienkamp HJ J Neurochem; 2020 Nov; 155(3):250-263. PubMed ID: 32202324 [TBL] [Abstract][Full Text] [Related]
2. Targeting of δ-catenin to postsynaptic sites through interaction with the Shank3 N-terminus. Hassani Nia F; Woike D; Martens V; Klüssendorf M; Hönck HH; Harder S; Kreienkamp HJ Mol Autism; 2020 Oct; 11(1):85. PubMed ID: 33115499 [TBL] [Abstract][Full Text] [Related]
3. Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength. Arons MH; Lee K; Thynne CJ; Kim SA; Schob C; Kindler S; Montgomery JM; Garner CC J Neurosci; 2016 Aug; 36(35):9124-34. PubMed ID: 27581454 [TBL] [Abstract][Full Text] [Related]
4. SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region. Mameza MG; Dvoretskova E; Bamann M; Hönck HH; Güler T; Boeckers TM; Schoen M; Verpelli C; Sala C; Barsukov I; Dityatev A; Kreienkamp HJ J Biol Chem; 2013 Sep; 288(37):26697-708. PubMed ID: 23897824 [TBL] [Abstract][Full Text] [Related]
5. The Shank/ProSAP N-Terminal (SPN) Domain of Shank3 Regulates Targeting to Postsynaptic Sites and Postsynaptic Signaling. Woike D; Tibbe D; Hassani Nia F; Martens V; Wang E; Barsukov I; Kreienkamp HJ Mol Neurobiol; 2024 Feb; 61(2):693-706. PubMed ID: 37656313 [TBL] [Abstract][Full Text] [Related]
6. The PSD protein ProSAP2/Shank3 displays synapto-nuclear shuttling which is deregulated in a schizophrenia-associated mutation. Grabrucker S; Proepper C; Mangus K; Eckert M; Chhabra R; Schmeisser MJ; Boeckers TM; Grabrucker AM Exp Neurol; 2014 Mar; 253():126-37. PubMed ID: 24382453 [TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signaling stimulates the expression and synaptic clustering of the autism-associated Neuroligin 3 gene. Medina MA; Andrade VM; Caracci MO; Avila ME; Verdugo DA; Vargas MF; Ugarte GD; Reyes AE; Opazo C; De Ferrari GV Transl Psychiatry; 2018 Mar; 8(1):45. PubMed ID: 29503438 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic and functional analysis of SHANK3 stop mutations identified in individuals with ASD and/or ID. Cochoy DM; Kolevzon A; Kajiwara Y; Schoen M; Pascual-Lucas M; Lurie S; Buxbaum JD; Boeckers TM; Schmeisser MJ Mol Autism; 2015; 6():23. PubMed ID: 26045941 [TBL] [Abstract][Full Text] [Related]
9. Disrupted extracellular matrix and cell cycle genes in autism-associated Shank3 deficiency are targeted by lithium. Ioannidis V; Pandey R; Bauer HF; Schön M; Bockmann J; Boeckers TM; Lutz AK Mol Psychiatry; 2024 Mar; 29(3):704-717. PubMed ID: 38123724 [TBL] [Abstract][Full Text] [Related]
10. A nuclear function for armadillo/beta-catenin. Tolwinski NS; Wieschaus E PLoS Biol; 2004 Apr; 2(4):E95. PubMed ID: 15024404 [TBL] [Abstract][Full Text] [Related]
11. Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression. Lee K; Vyas Y; Garner CC; Montgomery JM Synapse; 2019 Aug; 73(8):e22097. PubMed ID: 30868621 [TBL] [Abstract][Full Text] [Related]
12. Aristaless Related Homeobox (ARX) Interacts with β-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling. Cho IT; Lim Y; Golden JA; Cho G PLoS One; 2017; 12(1):e0170282. PubMed ID: 28103279 [TBL] [Abstract][Full Text] [Related]
13. Mutations affecting the N-terminal domains of SHANK3 point to different pathomechanisms in neurodevelopmental disorders. Woike D; Wang E; Tibbe D; Hassani Nia F; Failla AV; Kibæk M; Overgård TM; Larsen MJ; Fagerberg CR; Barsukov I; Kreienkamp HJ Sci Rep; 2022 Jan; 12(1):902. PubMed ID: 35042901 [TBL] [Abstract][Full Text] [Related]
14. Simplet/Fam53b is required for Wnt signal transduction by regulating β-catenin nuclear localization. Kizil C; Küchler B; Yan JJ; Özhan G; Moro E; Argenton F; Brand M; Weidinger G; Antos CL Development; 2014 Sep; 141(18):3529-39. PubMed ID: 25183871 [TBL] [Abstract][Full Text] [Related]
16. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas. Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715 [TBL] [Abstract][Full Text] [Related]
17. Shank3 is localized in axons and presynaptic specializations of developing hippocampal neurons and involved in the modulation of NMDA receptor levels at axon terminals. Halbedl S; Schoen M; Feiler MS; Boeckers TM; Schmeisser MJ J Neurochem; 2016 Apr; 137(1):26-32. PubMed ID: 26725465 [TBL] [Abstract][Full Text] [Related]
18. Distinct hydrophobic "patches" in the N- and C-tails of beta-catenin contribute to nuclear transport. Sharma M; Jamieson C; Lui C; Henderson BR Exp Cell Res; 2016 Nov; 348(2):132-145. PubMed ID: 27658570 [TBL] [Abstract][Full Text] [Related]
19. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Durand CM; Perroy J; Loll F; Perrais D; Fagni L; Bourgeron T; Montcouquiol M; Sans N Mol Psychiatry; 2012 Jan; 17(1):71-84. PubMed ID: 21606927 [TBL] [Abstract][Full Text] [Related]
20. Genotype and phenotype correlations for SHANK3 de novo mutations in neurodevelopmental disorders. Li Y; Jia X; Wu H; Xun G; Ou J; Zhang Q; Li H; Bai T; Hu Z; Zou X; Xia K; Guo H Am J Med Genet A; 2018 Dec; 176(12):2668-2676. PubMed ID: 30537371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]